Entac Medical Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $4.14M
Latest Deal Amount
  • Investors
  • 8

Entac Medical General Information

Description

Developer of noninvasive devices designed for the prediction and diagnosis of gastrointestinal and other medical conditions. The company's self-contained, noninvasive device is attached to the patient's abdomen after surgery and uses proprietary algorithms to detect a highly specific, clinically-proven biomarker that is highly correlated with the development of POI (Postoperative ileus), enabling healthcare practitioners to overcome postoperative ileus and make the surgery process convenient for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 680 Oakleaf Office Lane
  • Memphis, TN 38117
  • United States
+1 (901) 000-0000

Entac Medical Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Entac Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 31-Aug-2021 $4.14M 00.00 Completed Generating Revenue
5. Later Stage VC (Series B) 31-Jul-2020 00.00 00.000 000 Completed Generating Revenue
4. Later Stage VC (Series A2) 17-Apr-2018 00000 00.000 00.000 Completed Generating Revenue
3. Early Stage VC (Series A1) 05-Jan-2016 00000 00000 00.000 Completed Startup
2. Accelerator/Incubator 31-Aug-2013 $250K Completed Startup
1. Seed Round 20-Nov-2012 $250K $250K Completed Startup
To view Entac Medical’s complete valuation and funding history, request access »

Entac Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view Entac Medical’s complete cap table history, request access »

Entac Medical Patents

Entac Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200330066-A1 Enhanced detection and analysis of biological acoustic signals Pending 16-Apr-2019 0000000000

Entac Medical Executive Team (3)

Name Title Board Seat Contact Info
Buddy Lyons Jr. Co-Founder, Chief Executive Officer & Board Member
M. Andrew Forsdick Chief Financial Officer
John Cromwell MD Co-Founder & Chief Medical Officer
To view Entac Medical’s complete executive team members history, request access »

Entac Medical Board Members (8)

Name Representing Role Since
Anthony Lettich The Angel Roundtable Board Member 000 0000
Bryan Gulke Self Board Member 000 0000
Buddy Lyons Jr. Entac Medical Co-Founder, Chief Executive Officer & Board Member 000 0000
Jan Bouten Innova Memphis Board Member 000 0000
Richard Jones Entac Medical Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Entac Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Entac Medical Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Beresford Ventures Venture Capital Minority 000 0000 000000 0
Volcano Capital Venture Capital Minority 000 0000 000000 0
iSelect Fund Venture Capital Minority 000 0000 000000 0
Lagomaj Capital Venture Capital Minority 000 0000 000000 0
SAGE Business Advisors Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »